PET Scan in Treating Patients With Metastatic Prostate Cancer
11C-Methionine and 2-18F-Fluoro-2-Deoxy-D-Glucose PET Imaging in Patients With Progressive Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Listed as NCT00002981, this NA trial focuses on Prostate Cancer and remains completed. Sponsored by Memorial Sloan Kettering Cancer Center, it has been updated 12 times since 1997, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2023 — Jul 2023 [monthly]
Active Not Recruiting NA
-
Jun 2022 — Jun 2023 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Jun 2021 — Jun 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Jun 2020 [monthly]
Active Not Recruiting NA
-
Jan 2019 — Jan 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Jan 2019 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jan 1997
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .